Abstract
• Background: Nasolacrimal occlusion has been shown to improve the efficacy of some topically applied ocular drugs. The aim of this study was to investigate the effect of nasolacrimal occlusion on tropicamide-induced mydriasis. • Methods: We compared pupillary dilatation by 0.125% tropicamide with and without nasolacrimal occlusion in 40 healthy volunteers. • Results: Analysis of variance with repeated measures failed to show any advantage due to nasolacrimal occlusion in drug-induced mydriasis. • Conclusion: Nasolacrimal occlusion did not increase the mydriasis obtained with 0.125% tropicamide.
Original language | English |
---|---|
Pages (from-to) | 530-531 |
Number of pages | 2 |
Journal | Graefe's Archive for Clinical and Experimental Ophthalmology |
Volume | 233 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1995 |
Externally published | Yes |